- Home
- Publications
- Publication Search
- Publication Details
Title
Mucopolysaccharidosis Type VI, an Updated Overview of the Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 24, Pages 13456
Publisher
MDPI AG
Online
2021-12-15
DOI
10.3390/ijms222413456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The natural history of neurocognition in MPS disorders: A review
- (2021) Elsa Shapiro et al. MOLECULAR GENETICS AND METABOLISM
- Long-term impact of early initiation of enzyme replacement therapy in 34 MPS VI patients: A resurvey study
- (2021) Dafne D.G. Horovitz et al. MOLECULAR GENETICS AND METABOLISM
- Epidemiology of Mucopolysaccharidoses Update
- (2021) Betul Celik et al. Diagnostics
- Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy
- (2021) Paula Garcia et al. MOLECULAR GENETICS AND METABOLISM
- Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures
- (2021) David Sehnal et al. NUCLEIC ACIDS RESEARCH
- Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report
- (2021) Ming-Fang He et al. BMC Ophthalmology
- Double valve replacement in a patient with Maroteaux – Lamy syndrome as an ultimate team challenge
- (2021) Alexandros Agron Demis et al. Journal of Cardiothoracic Surgery
- MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment
- (2021) Eugeni Entchev et al. MOLECULAR GENETICS AND METABOLISM
- Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses
- (2020) Emil Kakkis et al. MOLECULAR GENETICS AND METABOLISM
- Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns
- (2020) Yin-Hsiu Chien et al. Orphanet Journal of Rare Diseases
- Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI—Indirect Proof of Principle on Its Pathogenicity
- (2020) Maria Francisca Coutinho et al. Diagnostics
- Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models
- (2020) Eugeni Entchev et al. PLoS One
- Advances in glycosaminoglycan detection
- (2020) Shaukat A. Khan et al. MOLECULAR GENETICS AND METABOLISM
- RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences
- (2020) Stephen K Burley et al. NUCLEIC ACIDS RESEARCH
- A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI
- (2020) Mike Broeders et al. Molecular Therapy-Methods & Clinical Development
- A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
- (2020) Barbara Zapała et al. Molecular Genetics and Metabolism Reports
- Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors
- (2020) Rita Ferla et al. Molecular Therapy-Methods & Clinical Development
- Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics
- (2019) Abdellah Tebani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: Systematic review
- (2019) Dalila Fernandes Gomes et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Enzyme replacement therapy outcomes across the disease spectrum: findings from the mucopolysaccharidosis VI Clinical Surveillance Program
- (2019) Paul R Harmatz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI
- (2019) Rokhsareh Jafaryazdi et al. MOLECULAR BIOLOGY REPORTS
- Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance
- (2019) Mehmet Umut Akyol et al. Orphanet Journal of Rare Diseases
- Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI
- (2019) Majid Aminzadeh et al. GENE
- Enzyme replacement therapy initiated in adulthood: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program
- (2019) Christina Lampe et al. MOLECULAR GENETICS AND METABOLISM
- Free urinary glycosylated hydroxylysine as an indicator of altered collagen degradation in the mucopolysaccharidoses
- (2019) Nina Patel et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Newborn Screening for Mucopolysaccharidoses: Results of a Pilot Study with 100 000 Dried Blood Spots
- (2019) Clifford Ronald Scott et al. JOURNAL OF PEDIATRICS
- Mucopolysaccharidoses: overview of neuroimaging manifestations
- (2018) Manal Nicolas-Jilwan et al. PEDIATRIC RADIOLOGY
- Disease and subtype specific signatures enable precise diagnosis of the mucopolysaccharidoses
- (2018) Jennifer T. Saville et al. GENETICS IN MEDICINE
- Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene
- (2018) Rosella Tomanin et al. HUMAN MUTATION
- The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover
- (2018) Sandra Pohl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI
- (2018) Min-Ju Chan et al. JOURNAL OF PEDIATRICS
- Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy
- (2018) Myriam Ley-Martos et al. MEDICINE
- Diagnosis of Attenuated Mucopolysaccharidosis VI: Clinical, Biochemical, and Genetic Pitfalls
- (2018) Filippo Pinto e Vairo et al. PEDIATRICS
- New treatment method for mucopolysaccharidosis type VI by liver transplantation
- (2018) Sumika Toyama et al. PEDIATRICS INTERNATIONAL
- Mucopolysaccharidosis VI pathophysiology diagnosis and treatment
- (2017) Paul Harmatz Frontiers in Bioscience-Landmark
- Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models
- (2017) Randy J. Chandler et al. HUMAN GENE THERAPY
- The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
- (2017) Peter D. Stenson et al. HUMAN GENETICS
- A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI
- (2017) Esmee Oussoren et al. MOLECULAR GENETICS AND METABOLISM
- The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
- (2017) P. Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene
- (2017) Ping Wang et al. VETERINARY PATHOLOGY
- Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
- (2017) Rita Ferla et al. Molecular Therapy-Methods & Clinical Development
- Short Communication Impact of early enzyme-replacement therapy for mucopolysaccharidosis VI: results of a long-term follow-up of Brazilian siblings
- (2016) J.F. Franco et al. GENETICS AND MOLECULAR RESEARCH
- Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI
- (2016) Lynda E. Polgreen et al. MOLECULAR GENETICS AND METABOLISM
- Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease
- (2016) Marialuisa Alliegro et al. MOLECULAR THERAPY
- Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H
- (2016) Gerald V. Raymond et al. Scientific Reports
- Proteomic Discovery and Development of a Multiplexed Targeted MRM-LC-MS/MS Assay for Urine Biomarkers of Extracellular Matrix Disruption in Mucopolysaccharidoses I, II, and VI
- (2015) Wendy E. Heywood et al. ANALYTICAL CHEMISTRY
- Long-term cognitive follow-up in children treated for Maroteaux-Lamy syndrome
- (2015) Berendine J. Ebbink et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Mucopolysaccharidosis enzyme production by bone marrow and dental pulp derived human mesenchymal stem cells
- (2015) Matilda Jackson et al. MOLECULAR GENETICS AND METABOLISM
- Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
- (2015) Jonathan M. Heppner et al. MOLECULAR GENETICS AND METABOLISM
- Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases
- (2015) Marta Gómez-Grau et al. PLoS One
- Formylglycine, a Post-Translationally Generated Residue with Unique Catalytic Capabilities and Biotechnology Applications
- (2014) Mason J. Appel et al. ACS Chemical Biology
- Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)-10-year follow-up of patients who previously participated in an MPS VI survey study
- (2014) Roberto Giugliani et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Similar Therapeutic Efficacy Between a Single Administration of Gene Therapy and Multiple Administrations of Recombinant Enzyme in a Mouse Model of Lysosomal Storage Disease
- (2014) Rita Ferla et al. HUMAN GENE THERAPY
- A Community-Based Study of Mucopolysaccharidosis Type VI in Brazil: The Influence of Founder Effect, Endogamy and Consanguinity
- (2014) Fabiana Moura Costa-Motta et al. HUMAN HEREDITY
- Prevalence rates of mucopolysaccharidoses in Poland
- (2014) Agnieszka Jurecka et al. JOURNAL OF APPLIED GENETICS
- Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment
- (2014) Michael Frohbergh et al. PLoS One
- Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature
- (2013) Agnieszka Jurecka et al. CLINICAL RHEUMATOLOGY
- Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI
- (2013) Piranit Nik Kantaputra et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI
- (2013) Paul R. Harmatz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
- (2013) Edward H. Schuchman et al. PLoS One
- Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation
- (2012) Young Bae Sohn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8
- (2012) Rita Ferla et al. HUMAN GENE THERAPY
- Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series
- (2012) Anke Thümler et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI
- (2012) Rosa Bartolomeo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
- (2012) Alon Lai et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Expert recommendations for the laboratory diagnosis of MPS VI
- (2012) T. Wood et al. MOLECULAR GENETICS AND METABOLISM
- Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats
- (2012) Katherine P Ponder et al. MOLECULAR THERAPY
- Mucopolysaccharidosis type VI in a Miniature Poodle-type dog caused by a deletion in the arylsulphatase B gene
- (2012) RD Jolly et al. NEW ZEALAND VETERINARY JOURNAL
- Loss of exon identity is a common mechanism of human inherited disease
- (2011) T. Sterne-Weiler et al. GENOME RESEARCH
- Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)
- (2011) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI
- (2011) Mahoko Furujo et al. MOLECULAR GENETICS AND METABOLISM
- Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene
- (2011) I. Gottwald et al. MOLECULAR GENETICS AND METABOLISM
- Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
- (2011) Efrat Eliyahu et al. PLoS One
- Diagnosis of the mucopolysaccharidoses
- (2011) T. J. A. Lehman et al. RHEUMATOLOGY
- Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008
- (2010) Hissa Moammar et al. ANNALS OF SAUDI MEDICINE
- Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis
- (2010) S. Ferrari et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases
- (2010) Kia Jane Langford-Smith et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI
- (2010) Sean Turbeville et al. MOLECULAR GENETICS AND METABOLISM
- Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer
- (2010) Gabriella Cotugno et al. MOLECULAR THERAPY
- Mucopolysaccharidosis VI
- (2010) Vassili Valayannopoulos et al. Orphanet Journal of Rare Diseases
- Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study
- (2009) JJ McGill et al. CLINICAL GENETICS
- Lentiviral-mediated correction of MPS VI cells and gene transfer to joint tissues
- (2009) Sharon Byers et al. MOLECULAR GENETICS AND METABOLISM
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI
- (2008) Fritz W. Lischka et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: Insight into mucopolysaccharidosis type VI
- (2008) Seiji Saito et al. MOLECULAR GENETICS AND METABOLISM
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- (2008) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started